Integrating histopathology with molecular profiles can enhance accuracy in cancer survival prediction, yet most existing multimodal methods treat molecular inputs as unstructured predictors rather than biologically organized entities. As a result, the learned cross-modal associations are difficult to interpret at the pathway level, and the biological significance of image–omics relationships remains obscure. We present Slide-Omics, a multimodal deep learning framework that jointly models whole-slide morphology and pathway-structured multi-omics data to yield interpretable survival estimates. Central to Slide-Omics is a bidirectional cross-attention mechanism: slide-to-omics attention identifies the biological pathways most informative given the observed tissue architecture, whereas omics-to-slide attention identifies the morphological patterns most informative given pathway activity. These complementary views are merged into a unified importance score for each KEGG pathway, producing an interpretable, pathway-level map linking phenotype to genotype. Our work makes two main contributions. First, we introduce bidirectional cross-attention as a principled strategy for modeling interactions between tissue morphology and molecular pathways, enabling cross-modal reasoning absent from prior multimodal survival models. Second, we biologically validate the derived pathway importance scores, demonstrating concordance with established disease mechanisms across multiple cancer types. Whole-slide representations are obtained either from a CNN encoder via HipoMap or from a Vision Transformer foundation model via UNI2, while multi-omics data—gene expression, DNA methylation, and copy number alterations—are structured into KEGG pathway matrices. Across four TCGA cohorts, Slide-Omics achieves competitive survival prediction performance while offering pathway-level interpretability that directly supports mechanistic insight and clinical decision-making. The source code and data are available at https://github.com/aimlx-labcpp/Slide-Omics.